ASCENDIS PHARMA A/S

CUSIP: 04351PAD3 Class: NOTE 2.250% 4/0

DAFNA Capital Management LLC's Holding History (CIK: 0001389933)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 4,000,000 Value ($000) $5,460 Avg Close — Range —
Q3 2025
Shares 4,000,000 Value ($000) $5,443 Avg Close — Range —
Q2 2025
Shares 4,000,000 Value ($000) $5,010 Avg Close — Range —
Q1 2025
Shares 4,000,000 Value ($000) $4,710 Avg Close — Range —
Q4 2024
Shares 4,000,000 Value ($000) $4,413 Avg Close — Range —
Q3 2024
Shares 4,000,000 Value ($000) $4,680 Avg Close — Range —
Q2 2024
Shares 4,000,000 Value ($000) $4,420 Avg Close — Range —
Q1 2024
Shares 4,000,000 Value ($000) $4,610 Avg Close — Range —
Q4 2023
Shares 4,000,000 Value ($000) $4,139 Avg Close — Range —
Q3 2023
Shares 4,000,000 Value ($000) $3,691 Avg Close — Range —
Q2 2023
Shares 4,000,000 Value ($000) $3,628 Avg Close — Range —